Font Size: a A A
Keyword [Dermatomyositis]
Result: 161 - 178 | Page: 9 of 9
161. The Effect And Mechanism Of TPH Cells In Dermatomyositis
162. Study Of 18F-FDG PET/CT?PET/MR Multimodality Imaging Application Value In Polymyositis-dermatomyositis
163. Clinical Analysis Of 63 Interstitial Lung Disease Patients With Positive Myositis Autoantibodies
164. Clinical Significance Of ICAM-1 And VCAM-1 In Dermatomyositis With Interstitial Lung Disease
165. Clinical Features And Concurrent Interstitial Lung Disease Risk Factors Of Dermatomyositis/Polymyositis
166. Risk And Prognostic Factors Of Anti-MDA5 Antibody Positive Dermatomyositis
167. The Meta-analysis Of Risk Factors Of Dermatomyositis Or Polymyositis Associated Cardiac Involvements
168. Electromyography And Clinical Characteristics In Patients With Dermatomyositis:A Retrospective Study
169. Retrospective Clinical Analysis Of 140 Cases Of Dermatomyositis
170. Application Of DTI And T2-mapping In The Assessment Of Polymyositis And Dermatomyositis
171. Clinical Features Of Dermatomyositis/Polymyositis With Positive Anti-MDA5 Antibody
172. Clinical Significance Of VEGF In Dermatomyositis/Polymyositis
173. Analysis Of Survival And Risk Factors Associated With Survival And Interstitial Lung Disease In Patients With Idiopathic Inflammatory Myopathy
174. The Analysis Of Clinical Phenotypes And Autoantibodies In Juvenile Dermatomyositis
175. Clinical Characteristics Of Polymyositis/Dermatomyositis Complicated With Interstitial Lung Disease And The Rule Of Differentiation And Treatment In TCM
176. Risk Factors And Survival Analysis Of Dermatomyositis Patients With Interstitial Lung Disease
177. Predictive Factors Associated With Interstitial Lung Disease In Patients With Dermatomyositis Or Polymyositis:A Meta-analysis
178. Predicting Rapid Progression Of Dermatomyositis Associated Interstitial Lung Disease With HRCT
  <<First  <Prev  Next>  Last>>  Jump to